ADVANCEMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PROGRAMS

Recombinant human serum albumin (OsrHSA) has emerged as a substantial innovation in the sphere of biopharmaceuticals, featuring promising breakthroughs across different professional medical and industrial apps. With its structural similarity to By natural means derived human serum albumin, OsrHSA delivers a safer, much more reliable alternative for